Risk Factors for Delirium in Patients with Acute Heart Failure: A Systematic Review and Meta-Analysis.

IF 1.7 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Tetsushi Kawazoe, Tomoaki Ishida, Kohei Jobu, Kei Kawada, Shumpei Morisawa, Junko Tomida, Naomi Iihara, Yoichi Kawasaki, Yukihiro Hamada
{"title":"Risk Factors for Delirium in Patients with Acute Heart Failure: A Systematic Review and Meta-Analysis.","authors":"Tetsushi Kawazoe, Tomoaki Ishida, Kohei Jobu, Kei Kawada, Shumpei Morisawa, Junko Tomida, Naomi Iihara, Yoichi Kawasaki, Yukihiro Hamada","doi":"10.1248/bpb.b24-00870","DOIUrl":null,"url":null,"abstract":"<p><p>Delirium is an acute, potentially life-threatening condition characterized by altered attention, disorganized thinking, and changes in consciousness. It frequently occurs in hospitalized patients with acute heart failure (AHF). In this meta-analysis, we aimed to identify risk factors for delirium in patients with AHF (AHF-D). We evaluated all original studies on delirium occurrence in patients hospitalized for AHF. On March 11, 2024, we searched PubMed, Scopus, Ichushi, and the Cochrane Library. Data extracted included: first author's name, publication year, inclusion/exclusion criteria, study design, delirium assessment methods, odds ratios with 95% confidence intervals, standardized mean differences, and other relevant findings. Of 2436 screened studies, 6 met eligibility criteria (3867 patients with AHF; 796 with delirium [20.6%] and 3071 without). Risk factors for AHF-D included older age; low body mass index; the use of mechanical ventilation/noninvasive positive pressure ventilation; comorbidities (previous stroke, dementia, and depression); use of antipsychotics and benzodiazepines; and laboratory findings on admission (elevated heart rate, B-type natriuretic peptide, blood urea nitrogen, serum creatinine, and low serum albumin and sodium levels). We identified 14 risk factors for AHF-D. These findings may help clinicians identify patients at high risk of developing AHF prior to delirium onset.</p>","PeriodicalId":8955,"journal":{"name":"Biological & pharmaceutical bulletin","volume":"48 7","pages":"1131-1141"},"PeriodicalIF":1.7000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biological & pharmaceutical bulletin","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1248/bpb.b24-00870","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Delirium is an acute, potentially life-threatening condition characterized by altered attention, disorganized thinking, and changes in consciousness. It frequently occurs in hospitalized patients with acute heart failure (AHF). In this meta-analysis, we aimed to identify risk factors for delirium in patients with AHF (AHF-D). We evaluated all original studies on delirium occurrence in patients hospitalized for AHF. On March 11, 2024, we searched PubMed, Scopus, Ichushi, and the Cochrane Library. Data extracted included: first author's name, publication year, inclusion/exclusion criteria, study design, delirium assessment methods, odds ratios with 95% confidence intervals, standardized mean differences, and other relevant findings. Of 2436 screened studies, 6 met eligibility criteria (3867 patients with AHF; 796 with delirium [20.6%] and 3071 without). Risk factors for AHF-D included older age; low body mass index; the use of mechanical ventilation/noninvasive positive pressure ventilation; comorbidities (previous stroke, dementia, and depression); use of antipsychotics and benzodiazepines; and laboratory findings on admission (elevated heart rate, B-type natriuretic peptide, blood urea nitrogen, serum creatinine, and low serum albumin and sodium levels). We identified 14 risk factors for AHF-D. These findings may help clinicians identify patients at high risk of developing AHF prior to delirium onset.

急性心力衰竭患者谵妄的危险因素:系统回顾和荟萃分析。
谵妄是一种急性的、可能危及生命的疾病,其特征是注意力改变、思维混乱和意识改变。它经常发生在急性心力衰竭(AHF)住院患者。在这项荟萃分析中,我们旨在确定AHF (AHF- d)患者谵妄的危险因素。我们评估了所有关于AHF住院患者谵妄发生的原始研究。在2024年3月11日,我们搜索了PubMed, Scopus, Ichushi和Cochrane Library。提取的资料包括:第一作者姓名、出版年份、纳入/排除标准、研究设计、谵妄评估方法、95%置信区间的优势比、标准化平均差异和其他相关发现。在筛选的2436项研究中,6项符合资格标准(3867例AHF患者;谵妄796例(20.6%),无谵妄3071例。AHF-D的危险因素包括年龄较大;低身体质量指数;机械通气/无创正压通气的使用;合并症(既往中风、痴呆和抑郁症);使用抗精神病药物和苯二氮卓类药物;入院时的实验室检查结果(心率升高、b型利钠肽、尿素氮、血清肌酐、血清白蛋白和钠水平低)。我们确定了AHF-D的14个危险因素。这些发现可以帮助临床医生在谵妄发作前识别出AHF的高风险患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.50
自引率
5.00%
发文量
247
审稿时长
2 months
期刊介绍: Biological and Pharmaceutical Bulletin (Biol. Pharm. Bull.) began publication in 1978 as the Journal of Pharmacobio-Dynamics. It covers various biological topics in the pharmaceutical and health sciences. A fourth Society journal, the Journal of Health Science, was merged with Biol. Pharm. Bull. in 2012. The main aim of the Society’s journals is to advance the pharmaceutical sciences with research reports, information exchange, and high-quality discussion. The average review time for articles submitted to the journals is around one month for first decision. The complete texts of all of the Society’s journals can be freely accessed through J-STAGE. The Society’s editorial committee hopes that the content of its journals will be useful to your research, and also invites you to submit your own work to the journals.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信